Cash flow Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 09:05:03 12/09/2024 pm IST			After market 01:29:06 am
6.035 ^EUR	-0.41%		6.073	+0.63%

05/09	Evotec, X-Chem to Collaborate on Early-Stage Drug Discovery	MT
05/09	Evotec SE and X-Chem Inc. Collaborates to Accelerate Early-Stage Drug Discovery	CI

dd7032af6d2d016fbf66da.lTtO_PS4K4m2dBpTOtBRf9woQWcHd4ngJd-xbf1IeeA.3nAmy63_U6THF0oYYr0aGINcAlE0MbuhEZLrKad-ErrzCCuzjYEeu_InSw

Published financial data: EVOTEC SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	446M	501M	618M	751M	781M
Total Revenues	446M	501M	618M	751M	781M
Cost of Goods Sold, Total	314M	375M	466M	577M	606M
Gross Profit	133M	126M	152M	174M	175M
Selling General & Admin Expenses, Total	65.76M	76.84M	105M	156M	170M
R&D Expenses	58.43M	63.94M	72.2M	76.64M	68.53M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	-66.56M	-66.05M	-65.33M	-79.1M	-64.09M
Other Operating Expenses, Total	57.63M	74.73M	112M	154M	174M
Operating Income	75.26M	51.01M	39.23M	20.33M	1M
Interest Expense, Total	-7.46M	-8.46M	-9.25M	-13.15M	-11.74M
Interest And Investment Income	2.34M	2.91M	2.3M	8.34M	9.26M
Net Interest Expenses	-5.11M	-5.56M	-6.96M	-4.81M	-2.48M
Income (Loss) On Equity Invest.	-2.21M	-10.43M	-16.57M	-15.96M	-20.75M
Currency Exchange Gains (Loss)	1.22M	-6.94M	7.84M	13.08M	-2.5M
Other Non Operating Income (Expenses)	70K	252K	-61K	-727K	1.79M
EBT, Excl. Unusual Items	69.23M	28.34M	23.48M	11.91M	-22.94M
Merger & Related Restructuring Charges	-787K	-	-	-	-
Impairment of Goodwill	-1.65M	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-43K	212M	-171M	-9.14M
Gain (Loss) On Sale Of Assets	-139K	-50K	-147K	-178K	-
Asset Writedown	-10.27M	-3.24M	-683K	-	-5.01M
Other Unusual Items	175K	806K	2.6M	5.61M	-43.5M
EBT, Incl. Unusual Items	56.56M	25.81M	237M	-154M	-80.59M
Income Tax Expense	19.33M	19.56M	21.47M	21.7M	3.32M
Earnings From Continuing Operations	37.23M	6.25M	216M	-176M	-83.91M
Net Income to Company	37.23M	6.25M	216M	-176M	-83.91M
Minority Interest	844K	-	-	-	-
Net Income - (IS)	38.07M	6.25M	216M	-176M	-83.91M
Net Income to Common Incl Extra Items	38.07M	6.25M	216M	-176M	-83.91M
Net Income to Common Excl. Extra Items	38.07M	6.25M	216M	-176M	-83.91M
Per Share Items
Net EPS - Basic	0.25	0.04	1.3	-0.99	-0.47
Basic EPS - Continuing Operations	0.25	0.04	1.3	-0.99	-0.47
Basic Weighted Average Shares Outstanding	150M	154M	166M	177M	177M
Net EPS - Diluted	0.25	0.04	1.3	-0.99	-0.47
Diluted EPS - Continuing Operations	0.25	0.04	1.3	-0.99	-0.47
Diluted Weighted Average Shares Outstanding	152M	155M	167M	177M	177M
Normalized Basic EPS	0.29	0.12	0.09	0.04	-0.08
Normalized Diluted EPS	0.29	0.11	0.09	0.04	-0.08
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	108M	88.31M	89.32M	81.77M	72.08M
EBITA	86.74M	63.14M	49.56M	27.75M	7.13M
EBIT	75.26M	51.01M	39.23M	20.33M	1M
EBITDAR	108M	89.15M	90.22M	82.3M	72.38M
Effective Tax Rate - (Ratio)	34.18	75.77	9.06	-14.09	-4.12
Total Current Taxes	12.63M	12.06M	16.4M	13.98M	7.92M
Total Deferred Taxes	6.71M	7.49M	5.07M	7.72M	-4.6M
Normalized Net Income	44.11M	17.71M	14.68M	7.44M	-14.34M
Interest on Long-Term Debt	2.64M	3.12M	3.73M	3.84M	5.83M
Non-Cash Pension Expense	203K	80K	98K	110K	-402K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	69.58M	65.76M	73.52M	77.73M	73.9M
Net Rental Expense, Total	291K	840K	895K	526K	298K
Imputed Operating Lease Interest Expense	60.1K	119K	132K	109K	49.41K
Imputed Operating Lease Depreciation	231K	721K	763K	417K	249K
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	3.65M	5.28M	7.8M	9.92M	9.63M
Total Stock-Based Compensation	3.65M	5.28M	7.8M	9.92M	9.63M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	277M	423M	699M	415M	511M
Short Term Investments	42.99M	59.35M	159M	303M	93.2M
Total Cash And Short Term Investments	320M	482M	858M	718M	604M
Accounts Receivable, Total	95.07M	101M	153M	202M	123M
Other Receivables	22.78M	21.72M	23.42M	54.42M	80.66M
Total Receivables	118M	122M	177M	257M	204M
Inventory	10.75M	13.58M	25.79M	29.82M	30.89M
Prepaid Expenses	9.17M	9.26M	19.21M	16.95M	18.4M
Other Current Assets, Total	11.75M	31.85M	20.95M	51.67M	45.71M
Total Current Assets	470M	659M	1.1B	1.07B	903M
Gross Property Plant And Equipment	346M	476M	686M	921M	1.16B
Accumulated Depreciation	-108M	-141M	-201M	-271M	-350M
Net Property Plant And Equipment	238M	336M	485M	650M	807M
Long-term Investments	41.23M	59M	282M	147M	142M
Goodwill	256M	247M	258M	275M	276M
Other Intangibles, Total	118M	99.61M	30.85M	23.82M	15.45M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	34.33M	24.95M	17.36M	10.33M	14.33M
Other Long-Term Assets, Total	23.68M	37.4M	61.98M	77.32M	95.23M
Total Assets	1.18B	1.46B	2.24B	2.26B	2.25B
Liabilities
Accounts Payable, Total	31.32M	42.55M	72.6M	97.28M	134M
Accrued Expenses, Total	30.9M	36M	35.46M	49.22M	50.9M
Short-term Borrowings	-	212K	-	-	-
Current Portion of Long-Term Debt	6.34M	15.18M	36.14M	1.56M	130M
Current Portion of Leases	14.39M	14.62M	14.47M	14.82M	19.12M
Current Income Taxes Payable	7.3M	3.36M	10.6M	8.99M	5.56M
Unearned Revenue Current, Total	73.4M	70.65M	127M	137M	108M
Other Current Liabilities	15.29M	25.89M	28.47M	29.17M	16.85M
Total Current Liabilities	179M	208M	325M	338M	465M
Long-Term Debt	325M	331M	326M	328M	308M
Long-Term Leases	117M	131M	136M	162M	169M
Unearned Revenue Non Current	38.82M	26.13M	34.48M	206M	155M
Pension & Other Post Retirement Benefits	14.09M	15.33M	12.95M	12.53M	11.99M
Deferred Tax Liability Non Current	21.2M	20.4M	17.69M	18.52M	18.14M
Other Non Current Liabilities	8.45M	7.78M	5.54M	4.87M	5.46M
Total Liabilities	704M	740M	857M	1.07B	1.13B
Common Stock, Total	151M	164M	177M	177M	177M
Additional Paid In Capital	787M	1.03B	1.43B	1.44B	1.45B
Retained Earnings	-441M	-434M	-216M	-392M	-476M
Comprehensive Income and Other	-19.56M	-37.52M	-12.64M	-37.4M	-30.64M
Total Common Equity	477M	723M	1.38B	1.19B	1.12B
Minority Interest	-	-	-	-	-
Total Equity	477M	723M	1.38B	1.19B	1.12B
Total Liabilities And Equity	1.18B	1.46B	2.24B	2.26B	2.25B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	151M	164M	176M	177M	177M
ECS Total Common Shares Outstanding	151M	164M	176M	177M	177M
Book Value / Share	3.17	4.42	7.81	6.72	6.33
Tangible Book Value	103M	376M	1.09B	889M	829M
Tangible Book Value Per Share	0.68	2.3	6.18	5.03	4.68
Total Debt	463M	492M	513M	507M	626M
Net Debt	143M	10.04M	-345M	-212M	22.09M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	14.87M
Debt Equivalent Oper. Leases	2.33M	6.72M	7.16M	4.21M	2.38M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	29.77M	39.71M	13.07M	16.04M	3.07M
Account Code - Inventory Valuation	6	6	8	8	8
Inventories - Raw Materials, Total	10.24M	13.31M	25.04M	27.92M	25.9M
Inventories - Work In Process, Total	945K	279K	750K	1.91M	4.99M
Buildings, Total	36.1M	56.6M	201M	240M	274M
Machinery, Total	150M	181M	258M	335M	401M
Full Time Employees	3.03K	3.57K	4.2K	4.95K	5.06K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	672K	782K	2.1M	2.83M	-
Order Backlog	-	446M	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	38.07M	6.25M	216M	-176M	-83.91M
Depreciation & Amortization - CF	35.64M	41.2M	55.6M	72.68M	86.03M
Amortization of Goodwill and Intangible Assets - (CF)	11.48M	12.13M	10.33M	7.42M	6.12M
Depreciation & Amortization, Total	47.12M	53.33M	65.93M	80.1M	92.16M
Amortization of Deferred Charges, Total - (CF)	1.69M	2.73M	1.68M	1.56M	822K
(Gain) Loss From Sale Of Asset	139K	-1K	142K	178K	-
(Gain) Loss on Sale of Investments - (CF)	-112K	-1.53M	-224M	172M	9.14M
Asset Writedown & Restructuring Costs	11.92M	3.24M	683K	-	5.01M
(Income) Loss On Equity Investments - (CF)	2.21M	17.27M	28.43M	15.1M	20.75M
Stock-Based Compensation (CF)	3.65M	5.28M	7.8M	9.92M	9.63M
Other Operating Activities, Total	6.32M	-4.99M	27.95M	-19.51M	-7.22M
Change In Accounts Receivable	-32.48M	-4.18M	-48.03M	-38.43M	-
Change In Inventories	-1.36M	-3.63M	-11.65M	-4.41M	-
Change In Accounts Payable	-2.03M	2.16M	31.34M	24.55M	-
Change in Unearned Revenues	-14.68M	-14.62M	63.08M	182M	-
Change In Income Taxes	12.35M	15.49M	18.85M	29.39M	-
Change in Other Net Operating Assets	-30.58M	-32.1M	-55.87M	-73.58M	-9.94M
Cash from Operations	42.22M	44.72M	122M	203M	36.44M
Capital Expenditure	-31.32M	-99.07M	-119M	-181M	-213M
Sale of Property, Plant, and Equipment	-	-	-	-	530K
Cash Acquisitions	-40.45M	-10.93M	-410K	-20.86M	2.09M
Sale (Purchase) of Intangible assets	-583K	-	-	-	-2.68M
Investment in Marketable and Equity Securities, Total	-14.28M	-38.85M	-117M	-209M	190M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-6.24M	-7.38M	-4.13M	-
Other Investing Activities, Total	-	-	-	-	10.36M
Cash from Investing	-86.63M	-155M	-244M	-416M	-13.29M
Long-Term Debt Issued, Total	292M	21.54M	30.79M	-	220M
Total Debt Issued	292M	21.54M	30.79M	-	220M
Long-Term Debt Repaid, Total	-82.94M	-26.69M	-36.68M	-53.11M	-135M
Total Debt Repaid	-82.94M	-26.69M	-36.68M	-53.11M	-135M
Issuance of Common Stock	1.9M	252M	404M	699K	219K
Other Financing Activities, Total	-	-	-	-	-12.85M
Cash from Financing	211M	246M	398M	-52.41M	71.96M
Foreign Exchange Rate Adjustments	1.13M	9.5M	-66K	-19.04M	644K
Miscellaneous Cash Flow Adjustments	-	-	-	-	-1K
Net Change in Cash	168M	146M	277M	-284M	95.75M
Supplemental Items
Cash Interest Paid	4.49M	3.46M	5.43M	9.8M	12.85M
Cash Income Tax Paid (Refund)	2.42M	9.8M	-6.03M	18.5M	12.9M
Levered Free Cash Flow	32.61M	-18.32M	4.87M	-150M	-69.8M
Unlevered Free Cash Flow	37.27M	-13.03M	10.65M	-142M	-62.47M
Change In Net Working Capital	30.32M	7.18M	-29.66M	65.06M	-50.29M
Net Debt Issued / Repaid	209M	-5.16M	-5.89M	-53.11M	84.6M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	4.82	2.41	1.33	0.57	0.03
Return on Total Capital	6.36	2.96	1.58	0.71	0.04
Return On Equity %	8.26	1.04	20.5	-13.7	-7.27
Return on Common Equity	8.45	1.04	20.5	-13.7	-7.27
Margin Analysis
Gross Profit Margin %	29.77	25.1	24.52	23.16	22.4
SG&A Margin	14.73	15.34	17.06	20.79	21.71
EBITDA Margin %	24.11	17.63	14.45	10.88	9.22
EBITA Margin %	19.43	12.6	8.02	3.69	0.91
EBIT Margin %	16.86	10.18	6.35	2.71	0.13
Income From Continuing Operations Margin %	8.34	1.25	34.87	-23.38	-10.74
Net Income Margin %	8.53	1.25	34.87	-23.38	-10.74
Net Avail. For Common Margin %	8.53	1.25	34.87	-23.38	-10.74
Normalized Net Income Margin	9.88	3.54	2.37	0.99	-1.83
Levered Free Cash Flow Margin	7.3	-3.66	0.79	-20.01	-8.93
Unlevered Free Cash Flow Margin	8.35	-2.6	1.72	-18.91	-7.99
Asset Turnover
Asset Turnover	0.46	0.38	0.33	0.33	0.35
Fixed Assets Turnover	2.73	1.75	1.5	1.32	1.07
Receivables Turnover (Average Receivables)